Abstract

Hypoxia is a discrepancy between the required energy of the cell in the mitochondrial oxidative phosphorylation system. The immediate cause of the deficiency is a decrease in the oxygen concentration in the mitochondria. Today there is a huge demand for the development of new anti-hypoxic drugs. t is known that 1,2,4-triazole compounds can have antimicrobial, anti-inflammatory, anti-hypoxic effects. Modification of the 1,2,4-triazole nucleus is a productive way to create original active molecules with a non-planar structure, for their binding to bio-target substrates. Derivatives of bis-1,2,4-triazoles may become potential compounds with anti-hypoxic action.
 The aim of our work was to synthesize new S-derivatives of 4-alkyl-5-(((3-(pyridine-4-yl)-1Н-1,2,4-triazole-5-yl)thio)methyl)-4Н-1,2,4-triazole-3-thiols, to investigate their physicochemical parameters using modern complex physicochemical research methods and to conduct primary pharmacological screening for anti-hypoxic activity in models of acute hypoxia with hypertension.
 The object of the study was the S-derivatives of 4-alkyl-5-(((3-(pyridine-4-yl)-1Н-1,2,4-triazole-5-yl)thio)methyl)-4Н-1,2,4-triazole-3-thiols. The structure of the synthesized compounds was confirmed by elemental analysis (CHNS), 1H NMR, the individuality of the molecules was proved by chromatographic mass spectral analysis. 1H NMR signals for substances are consistent with the proposed structure. The study of the anti-hypoxic activity of the got compounds of the series of S-substituted bis-1,2,4-triazoles was carried out on models of acute hypoxia with hypertension, where Mexidol (5%) 200 mg/kg as a reference drug.
 New S-derivatives of 4-methyl-5-(((3-(pyridine-4-yl)-1Н-1,2,4-triazole-5-yl)thio)methyl)-4Н-1,2,4-triazole-3-thiols (I a) and 4-ethyl-5-(((3-(pyridine-4-yl)-1Н-1,2,4-triazole-5-yl)thio)methyl)-4Н-1,2,4-triazole-3-thiols (I b) with acyl-aryl, acyl-alkyl and alkyl substituents. We studied their spectral parameters, physicochemical properties in the conditions of GC/MS, elemental analysis, 1H NMR spectroscopy. According to the results of biological studies on the anti-hypoxic effect, it was found that 1-((4-ethyl-5-(((3-(pyridine-4-yl)-1H-1,2,4-triazole-5-yl)thio)methyl)-4H-1,2,4-triazole-3-yl)thio)propane-2-one is a compound that exceeds the anti-hypoxic activity of Mexidol and increases the lifespan of rats by 1.0% relative to the reference drug.

Highlights

  • Гіпоксія – це невідповідність потребуємої енергії клітини у системі мітохондріального окисного фосфорилювання.

  • PARCHENKO (https://orcid.org/0000-0002-2283-1695) Zaporizhzhia State Medical University SYNTHESIS, PHYSICOCHEMICAL PROPERTIES AND ANTIGYPOXIC ACTIVITY OF SOME S-DERIVATIVES OF 4-ALKYL-5-(((3-(PYRIDIN-4-YL)-1H-1,2,4-TRIAZOL-5-YL) THIO)METHYL)-4H-1,2,4-TRIAZOLE-3-THIOL Key words: synthesis, 1,2,4-triazole, antihypoxic activity

  • Безпосередньою причиною недостатності є зниження концентрації кисню у мітохондріях.

Read more

Summary

Introduction

Гіпоксія – це невідповідність потребуємої енергії клітини у системі мітохондріального окисного фосфорилювання. PARCHENKO (https://orcid.org/0000-0002-2283-1695) Zaporizhzhia State Medical University SYNTHESIS, PHYSICOCHEMICAL PROPERTIES AND ANTIGYPOXIC ACTIVITY OF SOME S-DERIVATIVES OF 4-ALKYL-5-(((3-(PYRIDIN-4-YL)-1H-1,2,4-TRIAZOL-5-YL) THIO)METHYL)-4H-1,2,4-TRIAZOLE-3-THIOL Key words: synthesis, 1,2,4-triazole, antihypoxic activity Безпосередньою причиною недостатності є зниження концентрації кисню у мітохондріях. Антигіпоксанти являють собою лікарські засоби, які мають здатність підвищувати стійкість до кисневої недостатності та поліпшувати засвоєння кисню в організмі.

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call